From Medscape Diabetes & Endocrinology

Coverage from the

European Association for the Study of Diabetes (EASD) 2024 Annual Meeting

September 09 - 13, 2024; Madrid, Spain

September 09 - 13, 2024 Madrid, Spain

Conference News

EASD 2024 EU Program Aims to Ensure Safety for Pilots Who Use Insulin
Medscape Medical News, October 7, 2024
EASD 2024 Does Metformin Therapy Impact CVD in T2D? It's Complicated
Medscape Medical News, October 1, 2024
EASD 2024 New Guidelines Emphasize Liver Care in T2D, Obesity
Medscape Medical News, October 1, 2024
EASD 2024 Air Travel Alters Insulin Pump Delivery on Takeoff, Landing
Medscape Medical News, September 27, 2024
EASD 2024 Diabetes Registries Could Help Address Wobbly Data Dilemma
Medscape Medical News, September 25, 2024
EASD 2024 Tirzepatide Leads to Long-Term Glucose Control
Medscape Medical News, September 25, 2024
EASD 2024 'Call to Action': Greater CVD Focus Urged for T1D
Medscape Medical News, September 24, 2024
EASD 2024 Insulin Therapy De-Escalation to Fixed-Ratio Combo Safe
Medscape Medical News, September 23, 2024
EASD 2024 Hyperglycemia Linked to Mortality in Older Adults With T2D
Medscape Medical News, September 19, 2024
EASD 2024 Combining Semaglutide and Mineralocorticoids May Improve CKD
Medscape Medical News, September 19, 2024
EASD 2024 Fridays and Snacking Bad for Smart Insulin Pen Adherence
Medscape Medical News, September 19, 2024
EASD 2024 CGM Cuts Hospitalization in T2D, Even in Non-Insulin Treated
Medscape Medical News, September 18, 2024
EASD 2024 Guidance Will Aid Pediatric to Adult Diabetes Care Transfer
Medscape Medical News, September 18, 2024
EASD 2024 Short Steroid Treatment May Raise Diabetes Risk: Study
Medscape Medical News, September 17, 2024
EASD 2024 Will New Obesity Drugs Make Bariatric Surgery Obsolete?
Medscape Medical News, September 16, 2024
EASD 2024 Semaglutide Reduces MACE, Death in Impaired Kidney Function
Medscape Medical News, September 13, 2024
EASD 2024 Tirzepatide Real-World Safety Profile "Reassuring," So Far
Medscape Medical News, September 13, 2024
EASD 2024 Asthma and Type 2 Diabetes Have Bidirectional Relationship
Medscape Medical News, September 13, 2024

EASD 2024 SGLT2 Inhibitor Reduces Risk for Dementia, Alzheimer's in T2D
Medscape Medical News, September 13, 2024
EASD 2024 'Remarkable' Weight Loss With Novel Oral Combo in Phase 1
Medscape Medical News, September 12, 2024
EASD 2024 Eating Fruits and Oats Ups Type 1 Diabetes Risk in Some Kids
Medscape Medical News, September 12, 2024
EASD 2024 Icodec + Semaglutide Combo Shows Benefit in Type 2 Diabetes
Medscape Medical News, September 12, 2024
EASD 2024 Early vs Late Fast Window: Is One More Effective?
Medscape Medical News, September 12, 2024
EASD 2024 Diabetic Complications Increase Risk for Periodontitis
Medscape Medical News, September 12, 2024
EASD 2024 Liraglutide Reduces BMI by Almost 6% in Children Aged 6-12
Medscape Medical News, September 11, 2024
EASD 2024 Once-Weekly Insulin Looks Good in T2D, but Risk Seen in T1D
Medscape Medical News, September 11, 2024
EASD 2024 A Simple Blood Test May Predict Cancer Risk in T2D
Medscape Medical News, September 11, 2024
EASD 2024 AI Voice Analysis for Diabetes Screening Shows Promise
Medscape Medical News, September 11, 2024
EASD 2024 Finerenone Reduces T2D Onset in HF With Preserved EF
Medscape Medical News, September 10, 2024
EASD 2024 Do SGLT2 Inhibitors Benefit Everyone With T2D and CKD?
Medscape Medical News, September 10, 2024
EASD 2024 Night Owls May Be at Greater Risk for T2D, Beyond Lifestyle
Medscape Medical News, September 10, 2024
EASD 2024 Abnormal HR Shifts Tied to Risk for Death in Diabetes
Medscape Medical News, September 9, 2024
EASD 2024 Drugs, Complications, and Collaborations All on EASD Agenda
Medscape Medical News, August 30, 2024
EASD 2024 Men, Women, & Exercise: Metabolism Differs at Starting Line
Medscape Medical News, August 29, 2024
EASD 2024 New Data Shed Light on Type 1 Diabetes Male Predominance
Medscape Medical News, August 16, 2024
EASD 2024 Why Is Mom's T1D Half as Likely as Dad's to Pass to Child?
Medscape Medical News, August 6, 2024

Medscape Diabetes©

Perspectives

Diabetic Kidney Disease Therapies Keep on FLOWing
Kevin Fernando, MB BCh, MSc
Once-Weekly Insulin: A Game-Changer for Primary Care
Kevin Fernando, MB ChB, MSc

Popular News From EASD 2023

Weight Loss With Semaglutide Maintained for up to 3 Years Improvements in A1c and body weight seen at 6 months are maintained for up to 3 years with semaglutide, shows a large real-world data study.
Medscape Medical News, Oct 03, 2023
Common Meds Link to Sudden Cardiac Arrest in Type 2 Diabetes Real-world primary care data indicate that use of antipsychotics and antibiotics, among other meds, can significantly increase the risk of sudden cardiac arrest among people with type 2 diabetes.
Medscape Medical News, Oct 23, 2023
Low-Dose Aspirin Cuts Type 2 Diabetes Risk in Over-65s Aspirin also slowed the rise in fasting blood glucose over time, but its risks are still believed to outweigh its benefits, unless the individual has already had a first cardiac event.
Medscape Medical News, Sep 01, 2023

Previous Coverage

All material on this website is protected by copyright, Copyright © 1994-2025 by WebMD LLC. This website also contains material copyrighted by 3rd parties.